Nitrofurantoin-induced lung disease and prophylaxis of urinary tract infections

被引:22
作者
Madani, Yasser [1 ]
Mann, Bhupinder [1 ]
机构
[1] W Middlesex Univ Hosp, Dept Resp Med, London TW7 6AF, England
来源
PRIMARY CARE RESPIRATORY JOURNAL | 2012年 / 21卷 / 03期
关键词
nitrofurantoin; lung disease; drug-induced; fibrosis; urinary tract infection; prophylaxis; PULMONARY-FIBROSIS;
D O I
10.4104/pcrj.2012.00059
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Nitrofurantoin is commonly used for the treatment and prophylaxis of recurrent urinary tract infections (UTIs). Although relatively rare, nitrofurantoin is one of the commonest causes of drug-induced pulmonary disease, which can be potentially serious and even fatal. Knowledge of such potential adverse effects is essential to enable early recognition and withdrawal of the drug. Patients on long-term nitrofurantoin should be reviewed and monitored regularly. Management involves early consideration of the condition, and prompt withdrawal of the drug. We report three cases of nitrofurantoin-induced lung disease in patients who were on long-term nitrofurantoin for UTI prophylaxis and present a brief review of the literature on this subject. (C) 2012 Primary Care Respiratory Society UK. All rights reserved. Y Madani and B Mann. Prim Care Respir J 2012; 21(3): 337-341 http://dx.doi.org/10.4104/pcrj.2012.00059
引用
收藏
页码:337 / 341
页数:5
相关论文
共 50 条
  • [41] Antimicrobial prophylaxis in women with recurrent urinary tract infections
    Lichtenberger, Paola
    Hooton, Thomas M.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2011, 38 : 36 - 41
  • [42] Risks of long-term use of nitrofurantoin for urinary tract prophylaxis in the older patient
    Rego, Lauren L.
    Glazer, Craig S.
    Zimmern, Philippe E.
    UROLOGICAL SCIENCE, 2016, 27 (04) : 193 - 198
  • [43] Acute fatal nitrofurantoin-induced liver failure: a case report
    Cross, Elfriede
    Chuang, Ryan
    CLINICAL TOXICOLOGY, 2017, 55 (07) : 812 - 812
  • [44] Nitrofurantoin-induced lupus-like syndrome associated with hepatitis
    Salle, V
    Lafon, B
    Smail, A
    Cévallos, R
    Chatelain, D
    Andréjak, M
    Ducroix, JP
    REVUE DE MEDECINE INTERNE, 2006, 27 (04): : 344 - 346
  • [45] Pleural effusion: An uncommon manifestation of nitrofurantoin-induced pulmonary injury
    Davis, Jared W.
    Jones, Lynn S.
    RESPIRATORY MEDICINE CASE REPORTS, 2016, 19 : 65 - 67
  • [46] Nitrofurantoin-Induced Pulmonary Toxicity: Always Review the Medication List
    Batzlaff, Caitlin
    Koroscil, Matt
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (08)
  • [47] Nitrofurantoin-induced pulmonary toxicity: A case report and review of the literature
    Kabbara, Wissam K.
    Kordahi, Melissa C.
    JOURNAL OF INFECTION AND PUBLIC HEALTH, 2015, 8 (04) : 309 - 313
  • [48] Antibiotic prophylaxis in children with relapsing urinary tract infections: Review
    Mangiarotti, P
    Pizzini, C
    Fanos, V
    JOURNAL OF CHEMOTHERAPY, 2000, 12 (02) : 115 - 123
  • [49] Long-term antibiotic prophylaxis in urinary tract infections
    Toenshoff, B.
    Beetz, R.
    MONATSSCHRIFT KINDERHEILKUNDE, 2007, 155 (03) : 242 - +
  • [50] Nitrofurantoin-induced liver failure A fatal yet forgotten complication
    Luk, Trevor
    Edwards, Brett D.
    Bates, Duane
    Evernden, Christopher
    Edwards, Jenny
    CANADIAN FAMILY PHYSICIAN, 2021, 67 (05) : 342 - 344